Patents by Inventor George W. Ousler, III

George W. Ousler, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
    Publication number: 20120093876
    Abstract: The present invention provides process for producing non-aqueous compositions for normalizing meibomian gland secretions. The present invention further provides compositions and methods for treating and/or preventing the signs and/or symptoms of dry eye disease.
    Type: Application
    Filed: October 13, 2010
    Publication date: April 19, 2012
    Applicant: Aciex, Inc.
    Inventors: George W. Ousler, III, Matthew J. Chapin, Mark B. Abelson, George Minno, Aron Shapiro
  • OPHTHALMIC FORMULATIONS, METHODS OF MANUFACTURE, AND METHODS OF USING SAME
    Publication number: 20100311688
    Abstract: The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye. Methods of manufacture are also provided.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 9, 2010
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Matthew J. Chapin, George Minno, Jackie Nice, George W. Ousler, III, Mark B. Abelson
  • Formulations and Methods for Treating Dry Eye
    Publication number: 20100130580
    Abstract: The present invention provides compositions comprising a low dose amount of an ophthalmic NSAID for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye and safe for chronic use.
    Type: Application
    Filed: October 19, 2009
    Publication date: May 27, 2010
    Applicant: Aciex Therapeutics, Inc.
    Inventors: George W. Ousler, III, Matthew J. Chapin, Mark B. Abelson
  • Formulations and methods for treating dry eye
    Publication number: 20090010850
    Abstract: The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye.
    Type: Application
    Filed: May 23, 2008
    Publication date: January 8, 2009
    Inventors: George W. Ousler, III, Matthew J. Chapin, Mark B. Abelson
  • Methods and compositions for normalizing meibomian gland secretions
    Publication number: 20080312194
    Abstract: The present invention provides non-aqueous compositions for normalizing meibomian gland secretions, and methods of use thereof. The present invention further provides compositions and methods for treating and/or preventing the signs and/or symptoms of dry eye disease.
    Type: Application
    Filed: February 28, 2008
    Publication date: December 18, 2008
    Inventors: George W. Ousler, III, Matthew J. Chapin, Mark B. Abelson, George Minno, Aron Shapiro
  • Ophthalmic compositions
    Patent number: 6806364
    Abstract: An aqueous ophthalmic solution containing 0.2 to 2.5 percent by weight a polymeric demulcent, 0.045 to 0.065 percent by weight a calcium salt, and 0.14 to 1.4 percent by weight a phosphate salt. The solution has a viscosity of 20 to 150 centipoise and is buffered to a pH 5.5 to 8.5.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: October 19, 2004
    Assignees: AST Products, Inc., Ophthalmic Research Associates, Inc.
    Inventors: Shih-Horng Su, George W. Ousler, III
  • Instillation techniques for ophthalmic agents to enhance treatment effect
    Patent number: 6465506
    Abstract: The present invention provides methods for instilling an ophthalmic agent. One embodiment of a method according to the invention includes causing a patient to refrain from blinking for at least a specified period of time so as to effect the substantial break down of the patient's tear film covering the patient's eye and instilling an ophthalmic agent to the patient's eye.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: October 15, 2002
    Assignee: Ophthalmic Research Associates, Inc.
    Inventors: Mark B. Abelson, George W. Ousler, III